InvestSMART

EBR Systems Inc (ASX: EBR) - Announcements

Current share price for EBR : $0.155 0.015 (8.82%)+

ASX company news and announcements for EBR Systems Inc (EBR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All EBR Systems Inc (EBR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than EBR Systems Inc (EBR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for EBR Systems Inc (EBR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$131 Directors' Appendix 3Ys 23 May 2025 5:05PM $1.210 $0.155 fallen by 87.19%
$131 Proposed issue of securities - EBR 22 May 2025 1:35PM $1.215 $0.155 fallen by 87.24%
$131 Proposed issue of securities - EBR 22 May 2025 1:35PM $1.215 $0.155 fallen by 87.24%
$131 EBR Capital Raising Presentation 22 May 2025 1:35PM $1.215 $0.155 fallen by 87.24%
$131 EBR successfully completes a A$55.9 million Placemement 22 May 2025 1:34PM $1.215 $0.155 fallen by 87.24%
$131 Results of 2025 Annual Meeting of Stockholders 22 May 2025 12:25PM $1.215 $0.155 fallen by 87.24%
$131 Annual Meeting Presentation of EBR President & CEO 22 May 2025 8:38AM $1.215 $0.155 fallen by 87.24%
$131 Trading Halt 21 May 2025 8:11AM $1.215 $0.155 fallen by 87.24%
$131 Application for quotation of securities - EBR 20 May 2025 9:21AM $1.170 $0.155 fallen by 86.75%
$131 Notification regarding unquoted securities - EBR 19 May 2025 11:09AM $1.120 $0.155 fallen by 86.16%
$131 Notification of cessation of securities - EBR 16 May 2025 11:26AM $1.113 $0.155 fallen by 86.07%
$131 Q1 2025 Form 10-Q submission and Quarterly Activity Report 14 May 2025 9:05AM $1.180 $0.155 fallen by 86.86%
$131 Application for TPT Reimbursement for Outpatients Submitted 5 May 2025 8:41AM $1.265 $0.155 fallen by 87.75%
$131 Appointment of Additional Person for ASX Communications 16 Apr 2025 8:49AM $1.410 $0.155 fallen by 89.01%
$131 CMS Proposes Approval of NTAP Reimbursement 15 Apr 2025 8:28AM $1.400 $0.155 fallen by 88.93%
$131 Corporate Governance Statement and Appendix 4G 14 Apr 2025 8:57AM $1.690 $0.155 fallen by 90.83%
$131 Annual Report 14 Apr 2025 8:56AM $1.690 $0.155 fallen by 90.83%
$131 Notice of 2025 Annual Meeting 14 Apr 2025 8:52AM $1.690 $0.155 fallen by 90.83%
$131 CEO Investor Presentation for FDA PMA Approval Webinar 14 Apr 2025 8:34AM $1.690 $0.155 fallen by 90.83%
$131 FDA Approval of WiSE CRT System 14 Apr 2025 8:33AM $1.690 $0.155 fallen by 90.83%
$131 Notification regarding unquoted securities - EBR 4 Apr 2025 10:54AM $1.570 $0.155 fallen by 90.13%
$131 Notification of cessation of securities - EBR 3 Apr 2025 11:04AM $1.730 $0.155 fallen by 91.04%
$131 Update on Preparation of Preliminary Proxy Statement 2 Apr 2025 8:49AM $1.740 $0.155 fallen by 91.09%
$131 Application for quotation of securities - EBR 1 Apr 2025 12:03PM $1.810 $0.155 fallen by 91.44%
$131 Quarterly Cash Flow Report 25 Mar 2025 8:56AM $1.975 $0.155 fallen by 92.15%

151 - 175 of 517 results

Page 7 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.